acetovanillone has been researched along with angiotensinogen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, S; Chen, Y; Raizada, MK; Shenoy, V; Xiao, X; Yi, D; Zhang, C; Zhao, B | 1 |
| Huang, Y; Li, C; Liu, J; Lu, L; Ni, J; Shao, D; Shen, Y; Wang, R; Wang, Z; Xue, H; Yu, C; Yuan, P; Zhang, W; Zhou, L | 1 |
2 other study(ies) available for acetovanillone and angiotensinogen
| Article | Year |
|---|---|
Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy.
Topics: Acetophenones; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Cells, Cultured; Enzyme Inhibitors; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Peptides; Peptidyl-Dipeptidase A; Reactive Oxygen Species; Renin; Stem Cell Transplantation; Stroke; Transduction, Genetic | 2013 |
H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation.
Topics: Acetophenones; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Blood Glucose; Cell Proliferation; Cells, Cultured; Collagen Type IV; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Diabetes Mellitus, Experimental; Glucose; Hydrogen Sulfide; Hyperglycemia; Kidney; Losartan; Mesangial Cells; NADPH Oxidases; Onium Compounds; Peptidyl-Dipeptidase A; Rats; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Transforming Growth Factor beta1 | 2013 |